Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

203
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
203
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

389
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
389

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insulin resistance and obesity: Drivers of energy crisis for Alzheimer's disease.

International review of neurobiology·2026
Same author

Exploring the antibacterial potential of a designed peptide against Gardnerella vaginalis.

Molecular biology reports·2026
Same author

Transient receptor potential (TRP) channels: an emerging therapeutic target for the treatment of cardiac hypertrophy.

Expert opinion on therapeutic targets·2026
Same author

Transient Receptor Potential Channels in Modulating Synaptic Plasticity and Cognitive Function: Potential Role of Pharmacological Agents.

Basic & clinical pharmacology & toxicology·2026
Same author

Early detection of gastrointestinal cancers in low- and middle-income countries: A risk-stratified framework and implementation roadmap.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Multi-target machine learning for predicting mechanical properties of FDM-printed polymer components.

Scientific reports·2026

Related Experiment Video

Updated: Aug 26, 2025

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.5K

Apolipoprotein-mimetic Peptides: Current and Future Prospectives.

Sunil A Nankar1,2, Sakeel Ahmed3, Shyam Sunder Sharma3

  • 1Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar (Mohali)-160062, Punjab, India.

Current Protein & Peptide Science
|October 6, 2022
PubMed
Summary

Apolipoprotein-mimetic peptides show promise for treating central and peripheral diseases. This review covers the evolution from first-generation to advanced second-generation peptides, highlighting their therapeutic potential.

Keywords:
Alzheimer's diseaseApolipoproteinsCVDsHDLinflammationpeptides

More Related Videos

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

11.9K
Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library
13:37

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Published on: June 20, 2014

18.3K

Related Experiment Videos

Last Updated: Aug 26, 2025

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.5K
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

11.9K
Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library
13:37

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Published on: June 20, 2014

18.3K

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Apolipoprotein-mimetic peptides mimic apolipoproteins, offering therapeutic benefits for various diseases.
  • These peptides are being developed as potential treatments for central and peripheral diseases.
  • Significant advancements have been made from first-generation to second-generation peptides.

Approach:

  • This review discusses the structural and therapeutic potential of first-generation apolipoprotein-mimetic peptides.
  • It details the development of second-generation peptides, including dual-domain and bihelical structures.
  • The review emphasizes the emergence of second-generation peptides in preclinical and clinical studies.

Key Points:

  • First-generation peptides offer foundational structural and therapeutic insights.
  • Second-generation peptides, such as dual-domain and bihelical variants, represent significant advancements.
  • These advanced peptides demonstrate potential in various preclinical and clinical investigations.

Conclusions:

  • Apolipoprotein-mimetic peptides are evolving with enhanced therapeutic potential.
  • Second-generation peptides show promise for treating a range of diseases.
  • Continued research into these peptides may lead to novel therapeutic strategies.